Automated Bio-Decontamination for GMP Compliance

This white paper discusses Annex 1, a GMP document published by the European Commission, EMA, and PIC/S, which is crucial for pharmaceutical companies involved in sterile product manufacturing. It outlines the importance of compliance with Annex 1 for ensuring the safety, efficacy, and quality of sterile pharmaceutical products. As of August 25, 2023, compliance with all clauses of EU Volume 4 Annex 1 is required in Europe, with expectations for global adherence. The document details the significance of automated disinfection processes and highlights specific clauses that benefit from technology adoption, including the disinfection of cleanrooms and HVAC systems. It emphasizes the need for understanding and documenting disinfection methods to mitigate risks. The paper also presents the advantages of using outsourced services for implementing automated bio-decontamination technology, which can facilitate compliance with current regulations while minimizing operational disruptions. The use of vapour-phase hydrogen peroxide is discussed as an effective solution for meeting compliance requirements.